Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02648919 · ClinicalTrials.gov registry record · Phase 2
Clinical Study of Noni Extract in Men With Very Low Risk or Low Risk Prostate Cancer
A Phase 2 study, sponsored by University of Hawaii.
- Terminated
- Registry status
- Phase 2
- Development phase
- 6
- Enrollment target
NCT02648919 is a Phase 2 study that was terminated before completion, run by University of Hawaii. The registered enrollment target is 6 participants.
The verdict
NCT02648919, a Phase 2 study, was terminated before completion, sponsored by University of Hawaii.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 6 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the effects of Noni extract in men diagnosed with very low risk or low risk prostate cancer
Interventions
- DRUG Noni extract
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2015-12 |
| Est. Completion | 2018-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02648919
The ClinicalTrials.gov registry entry for NCT02648919 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Hawaii, which has 77 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Noni extract is the first listed.
NCT02648919 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02648919 about?
NCT02648919 is a clinical study titled "Clinical Study of Noni Extract in Men With Very Low Risk or Low Risk Prostate Cancer". The purpose of this study is to evaluate the effects of Noni extract in men diagnosed with very low risk or low risk prostate cancer
What is the current status of trial NCT02648919?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 6 participants. The study started on 2015-12. Estimated completion is 2018-12.
What interventions are being tested in trial NCT02648919?
The interventions under investigation include: Noni extract (DRUG).
Who is sponsoring clinical trial NCT02648919?
This trial is sponsored by University of Hawaii, which has 77 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.